Live feed07:00:00·1dPRReleasevia QuantisnowSAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosusByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCHealth Care
